PLx Pharma Winddown Corp.

2022 Q3 Form 10-Q Financial Statement

#000143774922020233 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.83M $35.73M $52.50M
YoY Change -68.71% -55.43% -37.81%
Cash & Equivalents $25.83M $35.73M $52.50M
Short-Term Investments
Other Short-Term Assets $1.070M $1.376M $712.0K
YoY Change 73.63% 136.83% 137.33%
Inventory $3.178M $3.883M $3.839M
Prepaid Expenses
Receivables $139.0K $490.0K $698.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.22M $41.48M $57.75M
YoY Change -65.9% -49.42% -31.96%
LONG-TERM ASSETS
Property, Plant & Equipment $768.0K $798.0K $828.0K
YoY Change -13.58% -13.15% -26.45%
Goodwill $2.061M $2.061M $2.061M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $174.0K $202.0K $17.00K
YoY Change 921.13% 1085.45% -15.0%
Total Long-Term Assets $3.003M $3.061M $3.110M
YoY Change -6.79% -7.12% -9.95%
TOTAL ASSETS
Total Short-Term Assets $30.22M $41.48M $57.75M
Total Long-Term Assets $3.003M $3.061M $3.110M
Total Assets $33.22M $44.54M $60.86M
YoY Change -63.82% -47.79% -31.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.069M $8.212M $12.72M
YoY Change -21.44% 244.71% 1224.58%
Accrued Expenses $1.238M $852.1K $511.1K
YoY Change 29.84% 31.45% 24.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.312M $9.068M $13.23M
YoY Change -14.76% 195.88% 838.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $46.00K $79.00K $106.0K
YoY Change -72.2% -59.38% -12.87%
Total Long-Term Liabilities $46.00K $79.00K $106.0K
YoY Change -72.2% -59.38% -12.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.312M $9.068M $13.23M
Total Long-Term Liabilities $46.00K $79.00K $106.0K
Total Liabilities $7.023M $12.04M $18.88M
YoY Change -84.37% -58.76% -15.26%
SHAREHOLDERS EQUITY
Retained Earnings -$179.4M -$171.0M -$159.1M
YoY Change 18.15% 31.34% 39.91%
Common Stock $189.6M $187.4M $185.0M
YoY Change 3.76% 10.04% 16.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.19M $16.49M $25.97M
YoY Change
Total Liabilities & Shareholders Equity $33.22M $44.54M $60.86M
YoY Change -63.82% -47.79% -31.09%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27539229
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27539229
CY2022Q2 plxp Reserves For Sales Returns And Consumer And Trade Promotion Obligations
ReservesForSalesReturnsAndConsumerAndTradePromotionObligations
1300000 usd
CY2021Q2 us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3072297
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
6476275
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17105849
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M7D
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36351
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4995704
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
2458000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1376000 usd
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28172468
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35730000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69392000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
490000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
634000 usd
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
3883000 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28172468
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28172468
dei Entity Address Address Line1
EntityAddressAddressLine1
9 Fishers Lane, Suite E
dei Entity Address City Or Town
EntityAddressCityOrTown
Sparta
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07871
dei City Area Code
CityAreaCode
973
dei Local Phone Number
LocalPhoneNumber
409-6541
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
PLXP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
930000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
930000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
992000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
41479000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
73476000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
798000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
858000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
2061000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
2061000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
202000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
247000 usd
CY2022Q2 us-gaap Assets
Assets
44540000 usd
CY2021Q4 us-gaap Assets
Assets
76642000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8212000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10600000 usd
CY2022Q2 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
729000 usd
CY2021Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
1163000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
127000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
116000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9068000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11879000 usd
CY2022Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2759000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
12818000 usd
CY2022Q2 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
129000 usd
CY2021Q4 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
129000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
136000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
12035000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
24962000 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
28000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
28000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
187380000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
183912000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170917000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148274000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
16491000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
35666000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44540000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76642000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
483000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2566000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
820000 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
1989000 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-337000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
577000 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
556000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
983000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1210000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1942000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13645000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5498000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32101000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8134000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
14201000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
6481000 usd
us-gaap Operating Expenses
OperatingExpenses
33311000 usd
us-gaap Operating Expenses
OperatingExpenses
10076000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14538000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6481000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-32734000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10076000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
29000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
32000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2651000 usd
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
10028000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10059000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17963000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2680000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10024000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10091000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17969000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11858000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16505000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22643000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28045000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11858000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16505000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22643000 usd
us-gaap Net Income Loss
NetIncomeLoss
-28045000 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
CY2021Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2203000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
-0 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2525000 usd
CY2022Q2 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-11858000 usd
CY2021Q2 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-18708000 usd
plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-22643000 usd
plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-30570000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36351
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4995704
dei Entity Address Address Line1
EntityAddressAddressLine1
9 Fishers Lane, Suite E
dei Entity Address City Or Town
EntityAddressCityOrTown
Sparta
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07871
dei City Area Code
CityAreaCode
973
dei Local Phone Number
LocalPhoneNumber
409-6541
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
PLXP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28172468
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3511000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1988000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
3883000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
2458000 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
100000 usd
us-gaap Inventory Write Down
InventoryWriteDown
300000 usd
CY2021Q4 plxp Reserves For Sales Returns And Consumer And Trade Promotion Obligations
ReservesForSalesReturnsAndConsumerAndTradePromotionObligations
1300000 usd
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
5700000 usd
us-gaap Advertising Expense
AdvertisingExpense
15300000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.53
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27693527
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23638239
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27616804
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20020012
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
35666000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1088000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10785000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
25969000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1050000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1330000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11858000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
16491000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-10932000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
573000 usd
CY2021Q1 plxp Financing Value
FinancingValue
66882000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-11540000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
44661000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
558000 usd
CY2021Q2 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
8361000 usd
CY2021Q2 plxp Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
3040000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16505000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40115000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22643000 usd
us-gaap Net Income Loss
NetIncomeLoss
-28045000 usd
us-gaap Inventory Write Down
InventoryWriteDown
312000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
60000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2138000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1131000 usd
plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-45000 usd
plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-29000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10059000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
17963000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-157000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-145000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1737000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1119000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
384000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
138000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2389000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1520000 usd
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-434000 usd
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-669000 usd
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
0 usd
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
-598000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-46000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-49000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34992000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9759000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
45000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
45000 usd
plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
1330000 usd
plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
66882000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1178000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
625000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1330000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67435000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33662000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
57721000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
69392000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22449000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35730000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80170000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
6000 usd
plxp Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
0 usd
plxp Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
1533000 usd
plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
0 usd
plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
8085000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35000000.0 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171000000.0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;">The preparation of our unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying unaudited consolidated financial statements, estimates are used for, but not limited to, the fair value of warrant liability, the fair value of stock-based compensation, trade promotional allowances, and allowance for inventory obsolescence. Actual results could differ from those estimates.</p>
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
372000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
132000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
0 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
338000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3511000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1988000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
3883000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
2458000 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
100000 usd
us-gaap Inventory Write Down
InventoryWriteDown
300000 usd
CY2021Q4 plxp Reserves For Sales Returns And Consumer And Trade Promotion Obligations
ReservesForSalesReturnsAndConsumerAndTradePromotionObligations
1300000 usd
us-gaap Advertising Expense
AdvertisingExpense
15300000 usd
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4198006
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
6596096
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
7557277
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
6476275
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17270377
us-gaap Operating Lease Expense
OperatingLeaseExpense
20000.00 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4198006
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
6596096
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
7557277
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
6476275
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
17270377
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;"><b>Reclassifications</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;">Certain reclassifications have been made to the prior-year financial statements to conform to the current-year presentation.  These reclassifications had <em style="font: inherit;">no</em> effect on the reported results of operations.</p>
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6596096
plxp Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
-0
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6596096
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.51
plxp Class Of Warrant Or Right Remaining Contractual Term
ClassOfWarrantOrRightRemainingContractualTerm
P5Y3M
CY2022Q2 plxp Class Of Warrant Or Right Aggregate Intrinsic Value
ClassOfWarrantOrRightAggregateIntrinsicValue
0 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
30000.00 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
10000.00 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6596096
plxp Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
-0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3498297
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.07
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7456000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
805000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.90
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2132339
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.72
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M13D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
89000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7700000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
30000.00 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
10000.00 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
60000.00 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
20000.00 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
68226000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
117917000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
31838000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
217981000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3498297
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.07
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7456000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
805000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
105291
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.59
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4198006
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.99
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M14D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
133000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2132339
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.72
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M13D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
89000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7700000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
60000.00 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
68226000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
117917000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
31838000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
217981000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16098000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
201883000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16098000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
201883000 usd

Files In Submission

Name View Source Status
0001437749-22-020233-index-headers.html Edgar Link pending
0001437749-22-020233-index.html Edgar Link pending
0001437749-22-020233.txt Edgar Link pending
0001437749-22-020233-xbrl.zip Edgar Link pending
ex_399737.htm Edgar Link pending
ex_399738.htm Edgar Link pending
ex_399739.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
plxp-20220630.xsd Edgar Link pending
plxp20220630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
plxp-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
plxp-20220630_lab.xml Edgar Link unprocessable
plxp-20220630_pre.xml Edgar Link unprocessable
plxp20220630_10q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
plxp-20220630_cal.xml Edgar Link unprocessable